Cargando…

Acute tolerance of Moderna mRNA-1273 vaccine against COVID-19 in patients with cancer treated with radiotherapy

Detalles Bibliográficos
Autores principales:	Scoccianti, Silvia, Delli Paoli, Camilla, Grilli Leonulli, Barbara, Paoletti, Lisa, Alpi, Paolo, Caini, Saverio, Barca, Raffaella, Fondelli, Simona, Russo, Serenella, Perna, Marco, Pino, Maria Simona, Martella, Francesca, Furlan, Federica, Bassetti, Andrea, Fioretto, Luisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354565/ https://www.ncbi.nlm.nih.gov/pubmed/34388385 http://dx.doi.org/10.1016/S1470-2045(21)00427-7

Ejemplares similares

Hypersensitivity reactions following the Moderna messenger RNA-1273 vaccine
por: Drohan, Alex, et al.
Publicado: (2021)

Paucisymptomatic COVID-19 in lung transplant recipient following two doses of mRNA-1273 (Moderna) vaccine
por: Marinelli, Tina, et al.
Publicado: (2021)

The Relationship Between Covid-19 Risk Perception and Vaccine Hesitancy in Cancer Patients: The Moderating Role of Externalizing Traits
por: Cheli, Simone, et al.
Publicado: (2022)

The national COVID-19 vaccination campaign targeting the extremely vulnerable: the Florence Medical Oncology Unit experience in patients with cancer
por: Pino, Maria S., et al.
Publicado: (2022)

Bullous Pemphigoid Following the Moderna mRNA-1273 Vaccine
por: Desai, Amar D, et al.
Publicado: (2022)

De novo vasculitis after mRNA-1273 (Moderna) vaccination
por: Anderegg, Manuel A., et al.
Publicado: (2021)

Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours
por: Oosting, Sjoukje F, et al.
Publicado: (2022)

Antibody response to the messenger RNA‐1273 vaccine (Moderna) in liver transplant recipients
por: Cuadrado, Antonio, et al.
Publicado: (2022)

Central retinal artery occlusion after Moderna mRNA-1273 vaccination
por: Chow, Sin Yu, et al.
Publicado: (2022)

Immune Thrombocytopenia Following Booster Dose of the Moderna mRNA-1273 Vaccine
por: Breetz, Katherine A, et al.
Publicado: (2022)

Purpuric Rash and Thrombocytopenia After the mRNA-1273 (Moderna) COVID-19 Vaccine
por: Malayala, Srikrishna V, et al.
Publicado: (2021)

New‐onset vitiligo following mRNA‐1273 (Moderna) COVID‐19 vaccination
por: Kaminetsky, Joshua, et al.
Publicado: (2021)

Pityriasis rosea after Moderna mRNA‐1273 vaccine: A case series
por: Martora, Fabrizio, et al.
Publicado: (2021)

Comment on Sycinska-Dziarnowska et al. The Implications of the COVID-19 Pandemic on the Interest in Orthodontic Treatment and Perspectives for the Future. Real-Time Surveillance Using Google Trends. Int. J. Environ. Res. Public Health 2021, 18, 5647
por: Livas, Christos, et al.
Publicado: (2021)

Re: Heterologous Gam-COVID-Vac (Sputnik V)/mRNA-1273 (Moderna) vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Choline PET/CT in recurrent prostate cancer
por: Detti, Beatrice, et al.
Publicado: (2023)

Herpes zoster reactivation after mRNA-1273 (Moderna) SARS-CoV-2 vaccination
por: Channa, Leelakrishna, et al.
Publicado: (2021)

Minimal change disease following the Moderna mRNA-1273 SARS-CoV-2 vaccine
por: Holzworth, Amy, et al.
Publicado: (2021)

Bell's palsy as a possible complication of mRNA-1273 (Moderna) vaccine against COVID-19
por: Poudel, Sujan, et al.
Publicado: (2022)

Heterologous Gam-COVID-Vac (Sputnik V)/mRNA-1273 (Moderna) vaccination: Author's response
por: Pereson, Matías J., et al.
Publicado: (2022)

Acquired Angioedema Acute Attack After Administration of the Moderna COVID-19 (mRNA-1273) Vaccine
por: Graziani, Alessandro, et al.
Publicado: (2023)

2336. General Safety Profile of mRNA-1273 (Moderna COVID-19 Vaccine) in the Elderly Population
por: Anteyi, Kate, et al.
Publicado: (2023)

Too many antibiotics for patients with COVID-19 despite low bacterial infections
por: Giacobbe, Daniele Roberto, et al.
Publicado: (2023)

EAN congress highlights challenges — predict, prevent, repair
por: Marson, Anthony G., et al.
Publicado: (2020)

Guillain‐Barré syndrome after mRNA‐1273 (Moderna) COVID‐19 vaccination: A case report
por: Anjum, Zauraiz, et al.
Publicado: (2022)

Cutaneous Sarcoidosis-like Eruption Following Second Dose of Moderna mRNA-1273 Vaccine: Case or Relationship?
por: Cazzato, Gerardo, et al.
Publicado: (2023)

2357. Descriptive Analyses of mRNA-1273 (Moderna COVID-19 vaccine) Spontaneous Reports by Geographic Regions
por: Emile-Backer, Magalie, et al.
Publicado: (2023)

Dissecting the mammary gland one cell at a time
por: Cristea, Simona, et al.
Publicado: (2018)

Comment on Boitrelle et al. The Sixth Edition of the WHO Manual for Human Semen Analysis: A Critical Review and SWOT Analysis. Life 2021, 11, 1368
por: Pallotti, Francesco, et al.
Publicado: (2022)

Bullous drug eruption after second dose of mRNA-1273 (Moderna) COVID-19 vaccine: Case report
por: Kong, Joyce, et al.
Publicado: (2021)

De-novo Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Following the mRNA-1273 (Moderna) Vaccine for COVID-19
por: Feghali, Elio Junior, et al.
Publicado: (2021)

Adult‐onset Still's disease following mRNA‐1273 Moderna COVID‐19 vaccination: A case report
por: Iwata, Masahiro, et al.
Publicado: (2022)

One world, one health, one virology of the mysterious labyrinth of coronaviruses: the canine coronavirus affair
por: Pratelli, Annamaria, et al.
Publicado: (2021)

Severe thrombocytopenia after trastuzumab retreatment: a case report
por: Pino, Maria Simona, et al.
Publicado: (2013)

Cutaneous skin manifestation following messenger RNA Moderna SARS-CoV-2 vaccine with dermal hypersensitivity reaction histopathology
por: Chopra, Shara, et al.
Publicado: (2021)

Comment on Menzel et al. Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice—Which to Use Regarding Disease Outcomes? Antioxidants 2021, 10, 414
por: Mrakic-Sposta, Simona, et al.
Publicado: (2021)

Cryptogenic stroke as a working diagnosis: the need for an early and comprehensive diagnostic work-up
por: Acampa, Maurizio, et al.
Publicado: (2023)

Two possible etiologies of Guillain-Barré syndrome: mRNA-1273 (Moderna) vaccination and scrub typhus: A case report
por: Hwang, Byoung Wook, et al.
Publicado: (2022)

Multiple Keratoacanthomas Following Moderna Messenger RNA-1273 COVID-19 Vaccination Resolved With 5-Fluorouracil Treatment: Case Report
por: Ahmed, Fahad, et al.
Publicado: (2022)

Ensuring continuity of care for children with inherited metabolic diseases at the time of COVID-19: the experience of a metabolic unit in Italy
por: Brunetti-Pierri, Nicola, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b8c93mbrfmgsnmj3icdbgg8gjl